Literature DB >> 32653453

The new role of F1Fo ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection.

Nelli Mnatsakanyan1, Elizabeth Ann Jonas2.   

Abstract

The mitochondrial F1Fo ATP synthase is one of the most abundant proteins of the mitochondrial inner membrane, which catalyzes the final step of oxidative phosphorylation to synthesize ATP from ADP and Pi. ATP synthase uses the electrochemical gradient of protons (ΔμH+) across the mitochondrial inner membrane to synthesize ATP. Under certain pathophysiological conditions, ATP synthase can run in reverse to hydrolyze ATP and build the necessary ΔμH+ across the mitochondrial inner membrane. Tight coupling between these two processes, proton translocation and ATP synthesis, is achieved by the unique rotational mechanism of ATP synthase and is necessary for efficient cellular metabolism and cell survival. The uncoupling of these processes, dissipation of mitochondrial inner membrane potential, elevated levels of ROS, low matrix content of ATP in combination with other cellular malfunction trigger the opening of the mitochondrial permeability transition pore in the mitochondrial inner membrane. In this review we will discuss the new role of ATP synthase beyond oxidative phosphorylation. We will highlight its function as a unique regulator of cell life and death and as a key target in mitochondria-mediated neurodegeneration and neuroprotection.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP synthase; Mitochondrial permeability transition pore; Neurodegeneration; Neuroprotection

Year:  2020        PMID: 32653453      PMCID: PMC7877222          DOI: 10.1016/j.expneurol.2020.113400

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  218 in total

1.  Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins.

Authors:  Jerry E Chipuk; John C Fisher; Christopher P Dillon; Richard W Kriwacki; Tomomi Kuwana; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

Review 2.  Cardiolipin and mitochondrial carriers.

Authors:  Martin Klingenberg
Journal:  Biochim Biophys Acta       Date:  2009-06-17

3.  The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel.

Authors:  I Szabó; V De Pinto; M Zoratti
Journal:  FEBS Lett       Date:  1993-09-13       Impact factor: 4.124

4.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

5.  Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion.

Authors:  G Paradies; G Petrosillo; M Pistolese; N Di Venosa; D Serena; F M Ruggiero
Journal:  Free Radic Biol Med       Date:  1999-07       Impact factor: 7.376

6.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

Authors:  Tilman Oltersdorf; Steven W Elmore; Alexander R Shoemaker; Robert C Armstrong; David J Augeri; Barbara A Belli; Milan Bruncko; Thomas L Deckwerth; Jurgen Dinges; Philip J Hajduk; Mary K Joseph; Shinichi Kitada; Stanley J Korsmeyer; Aaron R Kunzer; Anthony Letai; Chi Li; Michael J Mitten; David G Nettesheim; ShiChung Ng; Paul M Nimmer; Jacqueline M O'Connor; Anatol Oleksijew; Andrew M Petros; John C Reed; Wang Shen; Stephen K Tahir; Craig B Thompson; Kevin J Tomaselli; Baole Wang; Michael D Wendt; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg
Journal:  Nature       Date:  2005-05-15       Impact factor: 49.962

7.  Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.

Authors:  Natasa Dragicevic; Malgorzata Mamcarz; Yuyan Zhu; Robert Buzzeo; Jun Tan; Gary W Arendash; Patrick C Bradshaw
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case.

Authors:  S DiMauro; E Bonilla; C P Lee; D L Schotland; A Scarpa; H Conn; B Chance
Journal:  J Neurol Sci       Date:  1976-02       Impact factor: 3.181

9.  Mitofusin 2 tethers endoplasmic reticulum to mitochondria.

Authors:  Olga Martins de Brito; Luca Scorrano
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

10.  OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.

Authors:  Christian Frezza; Sara Cipolat; Olga Martins de Brito; Massimo Micaroni; Galina V Beznoussenko; Tomasz Rudka; Davide Bartoli; Roman S Polishuck; Nika N Danial; Bart De Strooper; Luca Scorrano
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

View more
  7 in total

Review 1.  The ATPase Inhibitory Factor 1 is a Tissue-Specific Physiological Regulator of the Structure and Function of Mitochondrial ATP Synthase: A Closer Look Into Neuronal Function.

Authors:  Sonia Domínguez-Zorita; Inés Romero-Carramiñana; José M Cuezva; Pau B Esparza-Moltó
Journal:  Front Physiol       Date:  2022-03-18       Impact factor: 4.755

Review 2.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15

3.  Morphological principles of neuronal mitochondria.

Authors:  Rachel Mendelsohn; Guadalupe C Garcia; Thomas M Bartol; Christopher T Lee; Priya Khandelwal; Emily Liu; Donald J Spencer; Adam Husar; Eric A Bushong; Sebastien Phan; Guy Perkins; Mark H Ellisman; Alexander Skupin; Terrence J Sejnowski; Padmini Rangamani
Journal:  J Comp Neurol       Date:  2021-11-01       Impact factor: 3.215

4.  Upregulation of miR-140-5p uncouples mitochondria by targeting Bcl-xL in vascular smooth muscle cells in angiotensin II-induced hypertension.

Authors:  Buxiong Tuo; Jie Xu; Wenqiang Zhang; Xiaomiao Li; Lijing Peng; Qian Zou; Ying Deng; Junning Lei; Hui Li
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 5.  Mitochondrial protein dysfunction in pathogenesis of neurological diseases.

Authors:  Liang Wang; Ziyun Yang; Xiumei He; Shiming Pu; Cheng Yang; Qiong Wu; Zuping Zhou; Xiaobo Cen; Hongxia Zhao
Journal:  Front Mol Neurosci       Date:  2022-09-07       Impact factor: 6.261

6.  Comparison of Effects of Metformin, Phenformin, and Inhibitors of Mitochondrial Complex I on Mitochondrial Permeability Transition and Ischemic Brain Injury.

Authors:  Kristina Skemiene; Evelina Rekuviene; Aiste Jekabsone; Paulius Cizas; Ramune Morkuniene; Vilmante Borutaite
Journal:  Biomolecules       Date:  2020-10-01

Review 7.  From the Structural and (Dys)Function of ATP Synthase to Deficiency in Age-Related Diseases.

Authors:  Caterina Garone; Andrea Pietra; Salvatore Nesci
Journal:  Life (Basel)       Date:  2022-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.